BIOMARKERS FOR DETECTION OF BREAST CANCERMethods are provided for predicting and diagnosing the presence of breast cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer.David E. ReeseRao V. Mulpuri...
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen[J] . Jana Jeschke,Leander Van Neste,Sabine C. Gl?ckner,Mashaal Dhir,Marilia Freitas Calmon,Val茅rie Deregowski,Wim Van Criekinge,Ilse Vlassenbroeck,Alexander Koch,Timothy A. Chan,Leslie Cope...
BIOMARKERS FOR THE EARLY DETECTION OF BREAST CANCER 来自 FreePatentsOnline 喜欢 0 阅读量: 99 申请(专利)号: 13809695 申请日期: 20110815 公开/公告号: WO2012021887 A2 申请(专利权)人: Joshua LaBaer;Karen Sue Anderson;Garrick Wallstrom;Sahar Sibani;Niroshan Ramachandran 发明人:...
Early detection of breast cancer: new biomarker tests on the horizon? When cancer is detected early, patients live longer, require less extensive treatment, and in general fare better than patients with more advanced disease... AC Jotwani,JR Gralow - 《Faseb Journal Official Publication of the...
In addition, we discuss the use of the Formalin-Fixed, Paraffin-Embedded (FFPE) tissue as an invaluable source for breast cancer biomarker discovery and validation, and the potential use of circulating miRNAs in blood for early breast cancer detection. We envision the potential use of miRNAs in...
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer Chae Young Han , Jacob S. Bedia & Robert C. Bast Jr Article | 05 January 2024 p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients...
Simple Summary: Breast cancer (BC) is the second leading cause of death in Canadian women. Despite this, non-invasive early detection methods for BC have y... N Hüttmann,Y Li,S Poolsup,... - 《Cancers》 被引量: 0发表: 2024年 Single-cell combined with bulk-RNA data reveal a patter...
Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers. 展开 被引量: 4 年份: 2006 ...
Low molecular weight (LMW) peptides have been discovered that are indicative of breast cancer. Evaluating patient samples for the presence of such LMW peptides is an effective means of detecting breast cancer and monitoring the progression of the disease, for example during treatment. The LMW ...
A high-throughput test enables specific detection of hepatocellular carcinoma ArticleOpen access07 June 2023 Introduction Breast Cancer (BC) is the most common malignancy with an incidence of 24.2% and mortality of 15% among all cancers in women. The mortality rates are higher in transitioning count...